|Reactive oxygen species regulate activation-induced T cell apoptosis|
DA Hildeman, T Mitchell, TK Teague, P Henson, BJ Day, J Kappler, ...
Immunity 10 (6), 735-744, 1999
|Interleukin 4 (IL-4) or IL-7 prevents the death of resting T cells: stat6 is probably not required for the effect of IL-4|
A Vella, TK Teague, J Ihle, J Kappler, P Marrack
The Journal of experimental medicine 186 (2), 325-330, 1997
|An inverse relationship between T cell receptor affinity and antigen dose during CD4+ T cell responses in vivo and in vitro|
W Rees, J Bender, TK Teague, RM Kedl, F Crawford, P Marrack, ...
Proceedings of the National Academy of Sciences 96 (17), 9781-9786, 1999
|IL-6 rescues resting mouse T cells from apoptosis.|
TK Teague, P Marrack, JW Kappler, AT Vella
The Journal of Immunology 158 (12), 5791-5796, 1997
|Immunological adjuvants promote activated T cell survival via induction of Bcl-3|
TC Mitchell, D Hildeman, RM Kedl, TK Teague, BC Schaefer, J White, ...
Nature immunology 2 (5), 397-402, 2001
|Activation changes the spectrum but not the diversity of genes expressed by T cells|
TK Teague, D Hildeman, RM Kedl, T Mitchell, W Rees, BC Schaefer, ...
Proceedings of the National Academy of Sciences 96 (22), 12691-12696, 1999
|Treatment of lentigo maligna with topical imiquimod|
MF Naylor, N Crowson, R Kuwahara, K Teague, C Garcia, C Mackinnis, ...
British Journal of Dermatology 149, 66-69, 2003
|Putative neuroprotective and neurotoxic kynurenine pathway metabolites are associated with hippocampal and amygdalar volumes in subjects with major depressive disorder|
J Savitz, WC Drevets, CM Smith, TA Victor, BE Wurfel, PSF Bellgowan, ...
Neuropsychopharmacology 40 (2), 463-471, 2015
|Reduction of kynurenic acid to quinolinic acid ratio in both the depressed and remitted phases of major depressive disorder|
J Savitz, WC Drevets, BE Wurfel, BN Ford, PSF Bellgowan, TA Victor, ...
Brain, behavior, and immunity 46, 55-59, 2015
|Relationship of collegiate football experience and concussion with hippocampal volume and cognitive outcomes|
R Singh, TB Meier, R Kuplicki, J Savitz, I Mukai, LM Cavanagh, T Allen, ...
Jama 311 (18), 1883-1888, 2014
|Thymocytes between the β-selection and positive selection checkpoints are nonresponsive to IL-7 as assessed by STAT-5 phosphorylation|
CJ Van De Wiele, JH Marino, BW Murray, SS Vo, ME Whetsell, ...
The Journal of Immunology 172 (7), 4235-4244, 2004
|Clinical effects of in situ photoimmunotherapy on late-stage melanoma patients: a preliminary study|
X Li, MF Naylor, H Le, RE Nordquist, TK Teague, CA Howard, C Murray, ...
Cancer biology & therapy 10 (11), 1081-1087, 2010
|In situ photoimmunotherapy: a tumour‐directed treatment for melanoma|
MF Naylor, WR Chen, TK Teague, LA Perry, RE Nordquist
British Journal of Dermatology 155 (6), 1287-1292, 2006
|Activation-induced inhibition of interleukin 6–mediated T cell survival and signal transducer and activator of transcription 1 signaling|
TK Teague, BC Schaefer, D Hildeman, J Bender, T Mitchell, JW Kappler, ...
The Journal of experimental medicine 191 (6), 915-926, 2000
|Inflammation and neurological disease-related genes are differentially expressed in depressed patients with mood disorders and correlate with morphometric and functional …|
J Savitz, MB Frank, T Victor, M Bebak, JH Marino, PSF Bellgowan, ...
Brain, behavior, and immunity 31, 161-171, 2013
|Relationship between neurotoxic kynurenine metabolites and reductions in right medial prefrontal cortical thickness in major depressive disorder|
TB Meier, WC Drevets, BE Wurfel, BN Ford, HM Morris, TA Victor, ...
Brain, behavior, and immunity 53, 39-48, 2016
|Neuroprotective kynurenine metabolite indices are abnormally reduced and positively associated with hippocampal and amygdalar volume in bipolar disorder|
J Savitz, R Dantzer, BE Wurfel, TA Victor, BN Ford, J Bodurka, ...
Psychoneuroendocrinology 52, 200-211, 2015
|Genomic-scale analysis of gene expression in resting and activated T cells|
P Marrack, T Mitchell, D Hildeman, R Kedl, TK Teague, J Bender, W Rees, ...
Current opinion in immunology 12 (2), 206-209, 2000
|Minocycline and aspirin in the treatment of bipolar depression: a protocol for a proof-of-concept, randomised, double-blind, placebo-controlled, 2× 2 clinical trial|
J Savitz, S Preskorn, TK Teague, D Drevets, W Yates, W Drevets
BMJ open 2 (1), 2012
|Treatment of bipolar depression with minocycline and/or aspirin: an adaptive, 2× 2 double-blind, randomized, placebo-controlled, phase IIA clinical trial|
JB Savitz, TK Teague, M Misaki, M Macaluso, BE Wurfel, M Meyer, ...
Translational psychiatry 8 (1), 1-11, 2018